Literature DB >> 20236144

Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: results of trial stimulation in 200 patients.

S Gallas1, F Michot, J L Faucheron, G Meurette, P A Lehur, X Barth, H Damon, F Mion, E Rullier, F Zerbib, I Sielezneff, M Ouaïssi, P Orsoni, V Desfourneaux, L Siproudhis, M Mathonnet, J F Menard, A M Leroi.   

Abstract

AIM: Sacral nerve stimulation (SNS) has a place in the treatment algorithm for faecal incontinence (FI). However, after implantation, 15-30% of patients with FI fail to respond for unknown reasons. We investigated the effect of SNS on continence and quality of life (QOL) and tried to identify specific predictive factors of the success of permanent SNS in the treatment of FI.
METHOD: Two hundred consecutive patients (six men; median age = 60; range 16-81) underwent permanent implantation for FI. The severity of FI was evaluated by the Cleveland Clinic Score. Quality of life was evaluated by the French version of the American Society of Colon and Rectal Surgeons (ASCRS) quality of life questionnaire (FIQL). All patients underwent a preoperative evaluation. After permanent implantation, severity and QOL scores were reevaluated after six and 12 months and then once a year.
RESULTS: The severity scores were significantly reduced during SNS (P = 0.001). QOL improved in all domains. At the 6-month follow-up, the clinical outcome of the permanent implant was not affected by age, gender, duration of symptoms, QOL, main causes of FI, anorectal manometry or endoanal ultrasound results. Only loose stool consistency (P = 0.01), persistent FI even though diarrhoea was controlled by medical treatment (P = 0.004), and low stimulation intensity (P = 0.02) were associated with improved short-term outcomes. Multivariate analysis confirmed that loose stool consistency and low stimulation intensity were related to a favourable outcome.
CONCLUSION: Stool consistency and low stimulation intensity have been identified as predictive factors for the short-term outcome of SNS.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20236144     DOI: 10.1111/j.1463-1318.2010.02260.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  14 in total

1.  Sacral neuromodulation for bowel dysfunction.

Authors:  J-L Faucheron; G Martin
Journal:  Tech Coloproctol       Date:  2013-06-06       Impact factor: 3.781

Review 2.  Current management of fecal incontinence: choosing amongst treatment options to optimize outcomes.

Authors:  Julie Ann M Van Koughnett; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

3.  [Sacral neuromodulation for refractory overactive bladder].

Authors:  Arndt van Ophoven
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

4.  Is sacral neuromodulation here to stay? Clinical outcomes of a new treatment for fecal incontinence.

Authors:  Bobby L Johnson; Adam Abodeely; Martha A Ferguson; Bradley R Davis; Janice F Rafferty; Ian M Paquette
Journal:  J Gastrointest Surg       Date:  2014-08-13       Impact factor: 3.452

5.  Sacral nerve stimulation for fecal incontinence. First successful case in Greece.

Authors:  C Spanos; Th Mikos; C Constantogiannis; G Georgantis; D Kiskinis
Journal:  Hippokratia       Date:  2011-10       Impact factor: 0.471

6.  Sacral neuromodulation for faecal incontinence: is the outcome compromised in patients with high-grade internal rectal prolapse?

Authors:  Siriluck Prapasrivorakul; Martijn P Gosselink; Martijn Gosselink; Kim J Gorissen; Simona Fourie; Roel Hompes; Oliver M Jones; Chris Cunningham; Ian Lindsey
Journal:  Int J Colorectal Dis       Date:  2014-11-30       Impact factor: 2.571

Review 7.  The role of percutaneous tibial nerve stimulation (PTNS) in the treatment of chronic anal fissure: a systematic review.

Authors:  Konstantinos Perivoliotis; Ioannis Baloyiannis; Dimitrios Ragias; Nikolaos Beis; Despoina Papageorgouli; Emmanouil Xydias; Konstantinos Tepetes
Journal:  Int J Colorectal Dis       Date:  2021-06-16       Impact factor: 2.571

8.  Baseline factors predictive of patient satisfaction with sacral neuromodulation for idiopathic fecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Bart van Wunnik; Steen Buntzen; Lilli Lundby; Søren Laurberg; Cor Baeten
Journal:  Int J Colorectal Dis       Date:  2014-04-18       Impact factor: 2.571

Review 9.  Management of patients with faecal incontinence.

Authors:  Jakob Duelund-Jakobsen; Jonas Worsoe; Lilli Lundby; Peter Christensen; Klaus Krogh
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

10.  Tools for fecal incontinence assessment: lessons for inflammatory bowel disease trials based on a systematic review.

Authors:  Ferdinando D'Amico; Steven D Wexner; Carolynne J Vaizey; Célia Gouynou; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-07-17       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.